Posted On: 11/02/2016 2:30:54 AM
Post# of 658
info: ARRY
Quote:
BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Tuesday reported a loss of $28.6 million in its fiscal first quarter.
On a per-share basis, the Boulder, Colorado-based company said it had a loss of 20 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The drug developer posted revenue of $39.3 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $37.2 million.
Array BioPharma shares have climbed 35 percent since the beginning of the year. The stock has climbed 11 percent in the last 12 months.
(0)
(0)
my "home" come for a visit here
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone
Don't be afraid to be outnumbered. Pigeons flock together. Eagle fly alone
